{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T20:35:42Z","timestamp":1723062942373},"reference-count":15,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T00:00:00Z","timestamp":1406332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.05.075","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T17:15:23Z","timestamp":1402334123000},"page":"6325-6329","source":"Crossref","is-referenced-by-count":1,"title":["Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam"],"prefix":"10.1016","volume":"32","author":[{"given":"Sonia","family":"Pagliusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahman","family":"Rustan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuvan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (5)","key":"10.1016\/j.vaccine.2014.05.075_bib0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0010","series-title":"Polio eradication & endgame, strategic plan 2013\u20132018, edition","author":"WHO, Rotary, CDC, UNICEF","year":"2013"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0015","series-title":"Presentation to DCVMN Annual General Meeting, Hanoi October","article-title":"Procurement advancements","author":"UNICEF","year":"2013"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0020","series-title":"WHO procedure for expedited review of imported prequalified vaccines for use in national immunization programmes","year":"2007"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0025","unstructured":"For additional information on UNICEF's MIC new vaccine procurement initiative, Available from http:\/\/www.unicef.org\/supply\/index_67101.html."},{"key":"10.1016\/j.vaccine.2014.05.075_bib0030","unstructured":"WHO position papers on vaccines, Available from http:\/\/www.who.int\/immunization\/documents\/positionpapers\/en\/."},{"key":"10.1016\/j.vaccine.2014.05.075_bib0035","series-title":"WHO guideline for the preparation of the product summary file for vaccine prequalification","year":"2006"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0040","series-title":"WHO clinical considerations for evaluation of vaccines for prequalification: points to consider for manufacturers of human vaccines","year":"2010"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0045","series-title":"WHO Assessing the programmatic suitability of vaccine candidates for WHO prequalification","year":"2012"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0050","series-title":"WHO guide to master formula","year":"2011"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0055","series-title":"WHO environmental monitoring of clean rooms in vaccine manufacturing facilities","year":"2012"},{"key":"10.1016\/j.vaccine.2014.05.075_bib0060","unstructured":"Priority setting for WHO vaccines prequalification programme for 2014\u20132015, Available from http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/pq_priorities\/en\/."},{"key":"10.1016\/j.vaccine.2014.05.075_bib0065","unstructured":"Guidance on variations to prequalified vaccines, Available from http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/variations_pq_vaccine\/en\/index.html."},{"key":"10.1016\/j.vaccine.2014.05.075_bib0070","unstructured":"WHO draft guidance on reporting variations to a prequalified vaccine; 2013, Available from http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/variations_1st_draft_public_comments_21feb2013.pdf."},{"key":"10.1016\/j.vaccine.2014.05.075_bib0075","series-title":"WHO guide on deviations handling and quality risk management: a note for guidance for the manufacture of prequalified vaccines for supply to United Nations agencies","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:21:12Z","timestamp":1538562072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14007750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":15,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14007750"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}